CMMB

Chemomab Therapeutics
CMMB

Overview Fund Trends Analyst Outlook Journalist POV

13 hedge funds and large institutions have $2.07M invested in Chemomab Therapeutics in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

67% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 6

Holders
13
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$20.4K
2
+$8.94K
3
+$1.87K

Top Sellers

1
-$108K
2
-$16.7K
3
-$14.8K
4
VF
Virtu Financial
New York
-$13K
5
Two Sigma Investments
Two Sigma Investments
New York
-$12.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.75M
2
$166K
3
$31.2K
4
$29.4K
5
$24.3K
6
$20.7K
7
$20.4K
8
$14.5K
9
$9.14K
10
$8.94K
11
$2.18K
12
$390
13
$34
14
$1
15
–
16
–
17
–
18
–
19
–
20
–